Systematic review of 28 studies (4423 participants) of urinary cell-free DNA for non-urothelial cancers: pooled sensitivity 0.80 and specificity 0.96, with high heterogeneity; limited post-treatment ucfDNA fall predicted poor prognosis (pooled HR 2.76).
Meta-analysisn = 4,423
Yajima et al. Diagnostic utility of urinary cell-free DNA in non-urothelial cancer: a systematic review, meta-analysis, & network meta-analysis